01 / DESIGN
What was studied?
Fourteen healthy adults participated in a blinded crossover comparison of defined oral formulations, followed by a short single-arm safety phase.
02 / FINDINGS
What did the researchers report?
The micellar preparation produced higher measured blood exposure than the standard preparation under the tested conditions. Short follow-up did not identify significant changes in selected safety markers.
03 / LIMITS
How should it be interpreted?
Small formulation-specific pharmacokinetic findings do not establish long-term clinical benefit. Oral preparations and research-supply materials are not interchangeable.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.